Lymphadenectomy in Ovarian Cancer: Is It Still Justified?
Sign Up to like & getrecommendations! Published in 2020 at "Current Oncology Reports"
DOI: 10.1007/s11912-020-0883-2
Abstract: Purpose of Review The aim of this review is to determine, in the light of recent evidences, the role of lymphadenectomy in ovarian cancer. Recent Findings The lymphadenectomy in ovarian neoplasms (LION) trial reports no… read more here.
Keywords: ovarian cancer; lymphadenectomy ovarian; oncology; cancer still ... See more keywords
Opinion: PARP inhibitors in cancer—what do we still need to know?
Sign Up to like & getrecommendations! Published in 2022 at "Open Biology"
DOI: 10.1098/rsob.220118
Abstract: PARP inhibitors (PARPi) have been demonstrated to exhibit profound anti-tumour activity in individuals whose cancers have a defect in the homologous recombination DNA repair pathway. Here, we describe the current consensus as to how PARPi… read more here.
Keywords: opinion parp; parp; cancer still; still need ... See more keywords
A genetic roadmap of pancreatic cancer: still evolving
Sign Up to like & getrecommendations! Published in 2017 at "Gut"
DOI: 10.1136/gutjnl-2016-313317
Abstract: A diagnosis of pancreatic ductal adenocarcinoma (PDA) is often fatal. PDA is widely recognised as one of the ‘incurable cancers’ because therapies against this tumour type are generally ineffective. The fatal nature of this tumour… read more here.
Keywords: roadmap pancreatic; cancer still; pancreatic cancer; still evolving ... See more keywords